Perry P K, Silverberg N B
Department of Dermatology, St. Luke's-Roosevelt Hospital Center, 1090 Amsterdam Ave, Suite 11D, New York, NY 10025, USA.
Cutis. 2001 May;67(5):427-30.
Albinism is a disorder of hypopigmentation affecting the skin, appendages, and eyes. Ultraviolet light-induced cutaneous tumors are common in patients with albinism due to reduced or absent protection from melanin. Squamous cell carcinoma (SCC) is the number one skin tumor seen in patients who are albinos. Although nonmelanomatous skin cancers are more common in patients with albinism, dysplastic nevus and melanoma present a greater diagnostic challenge in this group because of their hypopigmented appearance. We report 2 cases of cutaneous malignancies in patients who had oculocutaneous albinism (OCA). The first case involves a 45-year-old man with OCA type 2 (OCA2) who developed a large SCC of the neck. The second case involves a 24-year-old man with Hermansky-Pudiak syndrome (HPS) who developed amelanotic melanoma. In both cases, hypopigmentation of the lesions contributed to a delay in diagnosis. We review the clinical, diagnostic, and therapeutic concerns for patients with albinism who have cutaneous malignancies.
白化病是一种影响皮肤、附属器和眼睛的色素减退性疾病。由于黑色素保护减少或缺乏,紫外线诱导的皮肤肿瘤在白化病患者中很常见。鳞状细胞癌(SCC)是白化病患者中最常见的皮肤肿瘤。虽然非黑色素瘤性皮肤癌在白化病患者中更常见,但发育异常痣和黑色素瘤在该群体中因其色素减退的外观而带来更大的诊断挑战。我们报告2例患有眼皮肤白化病(OCA)的患者发生皮肤恶性肿瘤的病例。第一例病例是一名45岁的2型眼皮肤白化病(OCA2)男性,其颈部出现了一个大的鳞状细胞癌。第二例病例是一名24岁患有Hermansky-Pudiak综合征(HPS)的男性,其发生了无色素性黑色素瘤。在这两例病例中,病变的色素减退导致了诊断延迟。我们回顾了患有皮肤恶性肿瘤的白化病患者的临床、诊断和治疗问题。